CytomX Therapeutics Inc. (CTMX) declined -7.78% or -0.88 to $10.43. It is about 337421 shares traded, which is 78.67% compare to the average total volume 428880. The market cap of CTMX is $472.60 million. The year to date change is -35.37%. The 52 week price range is from $8.94 to $27.2. Price of CTMX have changed 0.44% during last week. It have changed 11.32% over last month, 0.80% over last 3 months, -20.35% over last 6 months and -55.79% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 10.54. It is 1.05% above current price. The 200-day Moving Averages for CTMX is 15.21. It is 45.83% above current price. The 52-week High is 27.2. It is 160.79% from the current price. The 52-week Low is 8.94. It is -14.29% from current price.
There are some statistics of CTMX. It is has market cap $472.60 million. The share outstanding is 45.31 million. The average volume is 428880. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -99.21%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -21.14%.